The International Pharmaceutical Federation (FIP) has announced the resignation of Mr Luc Besancon 
as Chief Executive Officer, effective 1 November, 2017. Disclosing the development via a press release from The Hague, the organisation revealed that Mr Besançon has decided to pursue other leadership roles in the global health arena.
Appraising the tenure of Besançon , President of FIP, Dr Carmen Peña said he has been a tremendous asset to FIP, all through his administration. “Luc resumed the responsibilities as CEO at a time of significant challenges after the unexpected passing of Mr Ton Hoek. During his tenure, Luc effectively led development of new member services and strengthened important relationships with key global health stakeholders such as the WHO. We wish him the very best.”
Speaking about his time at the federation, Mr. Besançon said: “It has been my great privilege and pleasure to have worked with so many inspirational volunteers, whose passion for our profession is the strongest asset of FIP. Key projects preparing FIP for a bright future are now well engaged. As I am considering the next step in my career, it seems that this would be the appropriate time for me to resign from my position as the FIP CEO.”
President Peña has formed a transition team to guide the global search for the new FIP CEO while maintaining a stable and effective organisation.
